Here are relevant reports on : ai-in-bioinformatics-market
-
Bioinformatics Services Market by Type (Sequencing, Data Analysis, Discovery, Gene Expression, Database Management), Specialty (Medical, Plant, Forensics), Application (Genomics, Metabolomics), Enduser (Academia, Pharma-biotech) - Global Forecast to 2026
The global bioinformatics services market growth is primed to transition from $2.5 billion in 2021 to $5.3 billion by 2026, showcasing a strong CAGR of 15.8%. Growing applications of bioinformatics across industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals (leading to increased outsourcing of bioinformatics projects) are the major factors that are expected to drive the growth of the bioinformatics services market during the forecast period.
- Published: July 2021
- Price: $ 4950
- TOC Available:
-
North America Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030
The North America Proteomics market, valued at US$13.06 billion in 2024, stood at US$14.11 billion in 2025 and is projected to advance at a resilient CAGR of 12.7% from 2025 to 2030, culminating in a forecasted valuation of US$25.62 billion by the end of the period. The growing use of proteomics in precision oncology, cardiology, and other complex diseases, together with strong momentum in clinical trials, is driving demand for high-throughput, reliable platforms in hospitals and research centers.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029
The global synthetic biology market, valued at US$11.97 billion in 2023, stood at US$12.33 billion in 2024 and is projected to advance at a resilient CAGR of 20.6% from 2024 to 2029, culminating in a forecasted valuation of US$31.52 billion by the end of the period. Some of the prominent factors driving the growth of the market include the rising demand for bio-based products, increased funding in R&D, and collaborations.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2030
The next-generation sequencing market, valued at US$13.95 billion in 2024, stood at US$14.94 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of US$29.53 billion by the end of the period. The next-generation sequencing (NGS) market continues to grow steadily. A key driver of this expansion is the clinical adoption of NGS across oncology, rare diseases, reproductive health, and infectious diseases. This trend is also accompanied by lower cost per genome and the launch of higher-throughput benchtop and clinical instruments.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Europe Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030
The Europe Proteomics market, valued at US$9.80 billion in 2024, stood at US$10.55 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$18.77 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030
The global genomics market, valued at US$44.52 billion in 2024, stood at US$47.07 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2024 to 2030, culminating in a forecasted valuation of US$85.09 billion by the end of the period. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Biopharma) - Global Forecast to 2030
The global proteomics market, valued at US$33.63 billion in 2024, stood at US$36.32 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2025 to 2030, culminating in a forecasted valuation of US$65.80 billion by the end of the period. The major factors driving growth in the proteomics market are the growing demand for personalized medicines for clinical practices, rising applications in drug discovery and development, growing government & private funding, clinical trial and translational research expansion, biologics and biosimilars development, increasing focus on monoclonal antibodies and therapeutic proteins, and improved techniques in protein quantification.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017
The Latin American bioinformatics market was valued at $242 million in 2012 and is poised to reach $627 million by 2017, at a CAGR of 22%. The Latin American bioinformatics market displays lucrative growth potential. It is propelled by the rising number of training and development programs on usage of bioinformatics tools, which leads to an increase in the use of bioinformatics tools by industrial and academic bioinformaticians in life sciences research. In addition, the market is further driven by the high concentration of bioinformatics research institutes in Latin America that aim to facilitate the use of bioinformatics in life sciences research. However, the dearth of skilled personnel and facilities to ensure the proper use of bioinformatics products and services and the dearth of advanced and innovative bioinformatics tools and algorithms are limiting the growth of the bioinformatics market in Latin America.
- Published: March 2014
- Price: $ 4950
- TOC Available:
-
Immune Repertoire Sequencing Market by Product (Instrument, Software, Assay Kit & Reagent (TCR, BCR Kit)), Technology (Sequencing, Bioinformatics), Service (Data Analysis), Application (Research, Drug Discovery & Development) - Global Forecast to 2030
Global immune repertoire sequencing market valued at $344.2M in 2024, reached $354.6M in 2025, and is projected to grow at a robust 9.6% CAGR, hitting $560.5M by 2030. The growth of the Asia Pacific IRS market is primarily due to growing R&D investments and the increasing presence of major industry stakeholders in the region.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029
The global gene expression analysis market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.
- Published: March 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
